AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Braskem S.A.

$2.01 -$0.91 (-31.16%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$2.08
Day Range
$1.96$2.07
Year Range
$1.4$5.39
Market Cap
800.95M
AVG Volume
2.44M
Trailing/Forward PE
-0.73/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
New York Stock ExchangeUS
Revenue (BRL)
050B100B150B2016201720182019202020212022202320242025
BAK Revenue (BRL) by year
PeriodRevenue (BRL)
202570.72B
202477.41B
202354.87B
202296.52B
2021105.63B
202058.54B
201952.32B
201858B
201749.26B
201648.14B
Net Income (BRL)
-20B-10B010B20B2016201720182019202020212022202320242025
BAK Net Income (BRL) by year
PeriodNet Income (BRL)
2025-9.88B
2024-11.32B
2023-4.73B
2022-883.14M
202113.98B
2020-7.1B
2019-2.4B
20182.87B
20173.87B
2016-546.26M
Operating Income (BRL)
-10B010B20B30B2016201720182019202020212022202320242025
BAK Operating Income (BRL) by year
PeriodOperating Income (BRL)
2025-1.68B
2024520M
2023-3.27B
20224.97B
202127.73B
2020-72.1M
20191.65B
20188.36B
20179.94B
20165.89B
EBITDA (BRL)
-10B010B20B30B2016201720182019202020212022202320242025
BAK EBITDA (BRL) by year
PeriodEBITDA (BRL)
20256.72B
2024-3.25B
20231.02B
20226.85B
202127.39B
2020-804.78M
20192.43B
201810.91B
201712.82B
20167.83B
Cash Flows (BRL)
-10B-5B05B10B15B2016201720182019202020212022202320242025
BAK Cash Flows (BRL) by year
PeriodCash Flows (BRL)
2025-7.35B
2024-1.32B
2023-6.8B
20224.1B
202111.37B
20203.53B
2019-694.5M
20186.54B
2017188.42M
20162.42B
EPS (BRL)
-40-20020402016201720182019202020212022202320242025
BAK EPS (BRL) by year
PeriodEPS (BRL)
2025-25.15
2024-28.42
2023-11.5
2022-2.2
202135.14
2020-17.86
2019-6.38
20187.2
20179.7
2016-1.1
Expenses (BRL)
05B10B15BR&DSG&ACapex2016201720182019202020212022202320242025
BAK Expenses (BRL) by year
PeriodExpenses (BRL)
20258.29B
20248.86B
20238.34B
202210.09B
20218.29B
20206.78B
20197.22B
20186.09B
20175.33B
20165.98B
Cash & Debt (BRL)
020B40B60B80BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
BAK Cash & Debt (BRL) by year
PeriodCash & Debt (BRL)
202511.84B
202416.77B
202319.14B
202214.76B
202112.17B
20203.37B
20192.75B
20185.6B
20174.26B
20167.47B
Debt ratios
024620182019202020212022202320242025
BAK Debt ratios by year
PeriodDebt ratios
20255.24
20241.78
20231.18
20221.09
20211.05
20200.33
20190.24
20180.78
Margins
0%10%20%30%40%2016201720182019202020212022202320242025
BAK Margins by year
PeriodMargins
20252.2%
20247.75%
20234.06%
202211.77%
202130.35%
202019.15%
201912.45%
201819.99%
201726.56%
201626.44%
Return on Capital
-500%0%500%1000%2016201720182019202020212022202320242025
BAK Return on Capital by year
PeriodReturn on Capital
202559.87%
2024264.61%
2023-144.2%
2022-14.46%
2021225.42%
2020954.07%
2019-244.39%
201848.5%
201770.63%
2016-31.75%
Shares Outstanding
0100M200M300M400M2016201720182019202020212022202320242025
BAK Shares Outstanding by year
PeriodShares Outstanding
2025398.6M
2024398.48M
2023398.6M
2022398.27M
2021398.03M
2020397.87M
2019397.87M
2018390M
2017397.87M
2016397.84M
Dividends (BRL)
01232011201220142015201620172018201920212022
BAK Dividends (BRL) by year
PeriodDividends (BRL)
20220.67
20212.63
20190.42
20181.11
20170.75
20161.49
20150.4
20140.54
20120.58
20111.03
Employee Count
02.5K5K7.5K10K2016201720182019202020212022202320242025
BAK Employee Count by year
PeriodEmployee Count
20258.23K
20248.38K
20238.57K
20228.67K
20218.31K
20207.99K
20197.94K
20188.01K
20177.71K
20167.66K
Book Value Per Share (BRL)
-60-40-200202016201720182019202020212022202320242025
BAK Book Value Per Share (BRL) by year
PeriodBook Value Per Share (BRL)
2025-41.4
2024-10.74
20238.23
202215.34
202115.59
2020-1.87
20192.46
201815.16
201713.76
20164.33
Total Assets (BRL)
050B100B150B2016201720182019202020212022202320242025
BAK Total Assets (BRL) by year
PeriodTotal Assets (BRL)
202581.88B
2024101.58B
202391.74B
202288.05B
202192.56B
202016.57B
201916.94B
201859.19B
201752.73B
201652.35B
PE Ratio
050100150200med 3.61Feb 20Nov 21Feb 22May 22Aug 22Nov 22Feb 23
BAK PE Ratio by year
PeriodPE Ratio
Feb 2310.4
Feb 2310.56
Feb 2311.56
Feb 2311.53
Jan 2312
Jan 2311.27
Jan 2312.3
Jan 2312.17
Dec 2212.65
Dec 2212.48
Dec 2211.89
Dec 2213.2
Dec 2214.74
Nov 223.61
Nov 223.61
Nov 223.93
Nov 224.09
Oct 224
Oct 224.29
Oct 224.42
Oct 223.41
Sep 223.23
Sep 223.55
Sep 223.55
Sep 223.85
Sep 224.01
Aug 221.7
Aug 221.77
Aug 221.88
Aug 221.85
Jul 221.92
Jul 221.79
Jul 221.81
Jul 221.8
Jul 221.96
Jun 221.99
Jun 221.96
Jun 222.29
Jun 222.42
May 222.46
May 222.49
May 222.4
May 222.28
Apr 222.32
Apr 222.32
Apr 222.49
Apr 222.56
Apr 222.53
Mar 222.61
Mar 222.67
Mar 222.61
Mar 222.73
Feb 222.67
Feb 222.82
Feb 222.99
Feb 223.04
Jan 222.86
Jan 222.7
Jan 222.92
Jan 222.95
Dec 213.27
Dec 213.19
Dec 213.06
Dec 213.02
Dec 213.41
Nov 214.32
Nov 214.05
Nov 214.17
Nov 214.7
Oct 214.68
Oct 214.7
Oct 215.04
Oct 214.94
Oct 215.09
Sep 214.95
Sep 215.62
Sep 215.74
Sep 215.71
Feb 20113.23
Feb 20127.66
Feb 20128.89
Feb 20132.37
Jan 20131.35
Jan 20156.49
Jan 20142.98
Jan 20143.1
Jan 20132.67
Free Cash Flow Yield
-300%-200%-100%0%med -76.44%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BAK Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-214.5%
Sep 26-207.28%
Sep 26-228.14%
Aug 26-253.68%
Aug 26-216.12%
Aug 26-217.37%
Aug 26-198.29%
Jul 26-195.02%
Jul 26-184.42%
Jul 26-183.62%
Jul 26-173.24%
Jul 26-180.78%
Jun 26-180.03%
Jun 26-152.16%
Jun 26-124.22%
Jun 26-128.24%
May 26-110.16%
May 26-94.81%
May 26-93.17%
May 26-102.17%
May 26-95.22%
Apr 26-108.96%
Apr 26-103.79%
Apr 26-97.54%
Apr 26-98.98%
Mar 26-82.75%
Mar 26-74.07%
Mar 26-65.41%
Mar 26-59.18%
Feb 26-77.71%
Feb 26-75.82%
Feb 26-76.38%
Feb 26-80.41%
Jan 26-81.81%
Jan 26-79.52%
Jan 26-91.43%
Jan 26-92.3%
Jan 26-96.43%
Dec 25-94%
Dec 25-98.38%
Dec 25-96.83%
Dec 25-96.13%
Nov 25-99%
Nov 25-95.47%
Nov 25-94.51%
Nov 25-109.37%
Oct 25-107.19%
Oct 25-100.93%
Oct 25-112.42%
Oct 25-110.13%
Oct 25-109.66%
Sep 25-103.58%
Sep 25-86.19%
Sep 25-81.21%
Sep 25-75.66%
Aug 25-76.5%
Aug 25-64.12%
Aug 25-71.57%
Aug 25-63.71%
Aug 25-65.66%
Jul 25-60.38%
Jul 25-65.17%
Jul 25-55.83%
Jul 25-59.93%
Jun 25-63.06%
Jun 25-56.97%
Jun 25-54.33%
Jun 25-53.89%
May 25-50.9%
May 25-15.22%
May 25-16.27%
May 25-16.13%
May 25-15.86%
Apr 25-14.71%
Apr 25-16.47%
Apr 25-16.57%
Apr 25-17.06%
Mar 25-14.59%
Mar 25-15.48%
Mar 25-15.03%
Mar 25-15.52%
Feb 25-15.2%
Feb 25-13.15%
Feb 25-12.68%
Feb 25-12.89%
Jan 25-12.27%
Jan 25-11.58%
Jan 25-13.12%
Jan 25-14.58%
Jan 25-14.2%
Dec 24-14.1%
Dec 24-13.65%
Dec 24-12.92%
Dec 24-11.36%
Nov 24-11.04%
Nov 24-10.79%
Nov 24-11.08%
Nov 24-10.49%
Nov 24-9.65%
Oct 24-9.58%
Price to Sales
00.050.10.150.2med 0.1Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BAK Price to Sales by year
PeriodPrice to Sales
Sep 260.06
Sep 260.06
Sep 260.05
Aug 260.05
Aug 260.06
Aug 260.06
Aug 260.07
Jul 260.07
Jul 260.07
Jul 260.08
Jul 260.08
Jul 260.08
Jun 260.08
Jun 260.09
Jun 260.11
Jun 260.11
May 260.13
May 260.15
May 260.15
May 260.1
May 260.11
Apr 260.1
Apr 260.1
Apr 260.11
Apr 260.11
Mar 260.1
Mar 260.11
Mar 260.13
Mar 260.14
Feb 260.11
Feb 260.11
Feb 260.11
Feb 260.1
Jan 260.1
Jan 260.1
Jan 260.09
Jan 260.09
Jan 260.09
Dec 250.09
Dec 250.08
Dec 250.09
Dec 250.09
Nov 250.08
Nov 250.09
Nov 250.09
Nov 250.07
Oct 250.07
Oct 250.07
Oct 250.07
Oct 250.07
Oct 250.07
Sep 250.07
Sep 250.09
Sep 250.09
Sep 250.1
Aug 250.1
Aug 250.09
Aug 250.08
Aug 250.09
Aug 250.08
Jul 250.09
Jul 250.09
Jul 250.1
Jul 250.09
Jun 250.09
Jun 250.1
Jun 250.1
Jun 250.1
May 250.11
May 250.11
May 250.11
May 250.11
May 250.11
Apr 250.12
Apr 250.1
Apr 250.1
Apr 250.1
Mar 250.12
Mar 250.11
Mar 250.12
Mar 250.11
Feb 250.12
Feb 250.13
Feb 250.14
Feb 250.14
Jan 250.14
Jan 250.15
Jan 250.14
Jan 250.12
Jan 250.12
Dec 240.13
Dec 240.13
Dec 240.14
Dec 240.16
Nov 240.16
Nov 240.16
Nov 240.16
Nov 240.17
Nov 240.18
Oct 240.19
EV/EBITDA
020406080med 17.67Dec 23Apr 24Jul 24Nov 25Feb 26Jun 26Sep 26
BAK EV/EBITDA by year
PeriodEV/EBITDA
Sep 266.64
Sep 266.66
Sep 266.62
Aug 266.58
Aug 266.64
Aug 266.64
Aug 269.46
Jul 269.47
Jul 269.51
Jul 269.51
Jul 269.55
Jul 269.52
Jun 269.52
Jun 269.66
Jun 269.85
Jun 269.82
May 269.99
May 2610.19
May 2610.21
May 269.92
May 2610
Apr 269.85
Apr 269.9
Apr 269.97
Apr 269.96
Mar 2617.87
Mar 2618.12
Mar 2618.42
Mar 2618.7
Feb 2618.01
Feb 2618.06
Feb 2618.05
Feb 2617.93
Jan 2617.9
Jan 2617.96
Jan 2617.68
Jan 2617.66
Jan 2617.58
Dec 2517.62
Dec 2517.54
Dec 2517.57
Dec 2517.58
Nov 2517.53
Nov 2517.6
Nov 2517.61
Nov 2510.7
Oct 2510.72
Oct 2510.78
Oct 2510.67
Oct 2510.69
Oct 2510.7
Sep 2510.75
Sep 2510.95
Sep 2511.02
Sep 2511.12
Aug 2511.1
Aug 2469.91
Aug 2469.57
Aug 2469.77
Aug 2469.08
Jul 2470.77
Jul 2470.72
Jul 2471.96
Jul 2471.09
Jun 2470.59
Jun 2470.58
Jun 2471.05
Jun 2470.18
May 2471.41
May 2454.84
May 2454.97
May 2454.78
May 2457.83
Apr 2457.81
Apr 2457.5
Apr 2458.53
Apr 2460.14
Mar 2460.58
Mar 2461.05
Mar 2456.6
Mar 2455.55
Mar 2456.98
Feb 2444.31
Feb 2442.85
Feb 2439.89
Feb 2440.19
Jan 2441.78
Jan 2440.43
Jan 2442.35
Jan 2444.01
Dec 2345.73
Dec 2346.21
Dec 2339.82
Dec 2340.22
Dec 2341.01
Nov 237.37
Nov 237.34
Nov 237.28
Nov 236.74
Oct 236.71
Price/Operating Cashflow
05101520med 3.85Mar 23Jun 23Sep 23Jul 24Oct 24Feb 25May 25
BAK Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
May 253.57
May 253.34
May 253.37
May 253.43
Apr 253.7
Apr 253.3
Apr 253.28
Apr 253.19
Mar 253.46
Mar 253.26
Mar 253.36
Mar 253.26
Feb 253.32
Feb 253.84
Feb 253.99
Feb 253.92
Jan 254.12
Jan 254.36
Jan 253.85
Jan 253.47
Jan 253.56
Dec 243.58
Dec 243.7
Dec 243.91
Dec 244.45
Nov 244.58
Nov 244.68
Nov 244.56
Nov 244.82
Nov 245.23
Oct 245.28
Oct 245.49
Oct 245.71
Oct 2416.81
Sep 2417.08
Sep 2415.8
Sep 2416.2
Sep 2415.87
Aug 2414.86
Aug 249.28
Aug 249.09
Aug 249.2
Aug 248.83
Jul 249.74
Jul 249.71
Jul 2410.39
Jul 249.92
Jun 249.64
Jun 249.64
Jun 249.9
Jun 249.42
May 2410.09
Nov 233.65
Nov 233.63
Nov 233.58
Nov 233.19
Oct 233.17
Oct 233.29
Oct 233.45
Oct 233.47
Sep 233.71
Sep 233.71
Sep 233.96
Sep 234.32
Sep 233.99
Aug 233.96
Aug 234.1
Aug 234.29
Aug 234.22
Jul 234.38
Jul 234.39
Jul 234.61
Jul 234.85
Jun 235
Jun 235.19
Jun 235.38
Jun 234.57
Jun 234.27
May 232.03
May 232.12
May 232.16
May 232.02
Apr 231.74
Apr 231.65
Apr 231.84
Apr 231.73
Mar 231.73
Mar 231.59
Mar 231.69
Mar 231.74
Mar 231.82
Feb 231.46
Feb 231.49
Feb 231.63
Feb 231.62
Jan 231.69
Jan 231.59
Jan 231.73
Jan 231.71
Dec 221.78
Price to Book
05101520med 12.5Dec 22Mar 23Jun 23Oct 23Jan 24May 24Aug 24
BAK Price to Book by year
PeriodPrice to Book
Aug 245.86
Aug 245.74
Aug 245.81
Aug 245.57
Jul 246.15
Jul 246.13
Jul 246.56
Jul 246.26
Jun 246.09
Jun 246.09
Jun 246.25
Jun 245.95
May 246.37
May 244.65
May 244.69
May 244.63
May 245.58
Apr 245.57
Apr 245.48
Apr 245.79
Apr 246.3
Mar 246.43
Mar 246.58
Mar 245.19
Mar 244.87
Mar 245.31
Feb 2418.66
Feb 2417.76
Feb 2415.92
Feb 2416.1
Jan 2417.09
Jan 2416.25
Jan 2417.44
Jan 2418.48
Dec 2319.54
Dec 2319.84
Dec 2315.88
Dec 2316.12
Dec 2316.62
Nov 2311.55
Nov 2311.49
Nov 2311.34
Nov 2310.09
Oct 2310.03
Oct 2310.41
Oct 2310.92
Oct 2311
Sep 2311.75
Sep 2311.74
Sep 2312.53
Sep 2313.69
Sep 2312.65
Aug 2312.48
Aug 2312.91
Aug 2313.52
Aug 2313.27
Jul 2313.8
Jul 2313.82
Jul 2314.5
Jul 2315.26
Jun 2315.74
Jun 2316.32
Jun 2316.95
Jun 2314.38
Jun 2313.43
May 232.98
May 233.11
May 233.17
May 232.95
Apr 232.56
Apr 232.41
Apr 232.7
Apr 232.54
Mar 232.54
Mar 232.33
Mar 232.47
Mar 232.55
Mar 232.67
Feb 2312.6
Feb 2312.8
Feb 2314.01
Feb 2313.98
Jan 2314.55
Jan 2313.65
Jan 2314.91
Jan 2314.75
Dec 2215.33
Dec 2215.12
Dec 2214.42
Dec 2216
Dec 2217.86
Nov 2215.31
Nov 2215.32
Nov 2216.67
Nov 2217.39
Oct 2216.98
Oct 2218.22
Oct 2218.77
Oct 2214.47
Sep 2213.71
Braskem S.A.
BAK
Stockpicker

Video analysis: BAK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BAK

China BAK Battery Highlights India Order, AI Data Center Backup-Power Push

marketbeat.com · 27 Aug 2026

China BAK Battery Highlights India Order, AI Data Center Backup-Power Push

China BAK Battery NASDAQ: CBAT, which operates as CBAK Energy, said it is expanding production capacity, pursuing growth in electric mobility and energy-storage markets, and testing a new battery cell for AI data center backup-power applications.

Braskem S.A. (BAK) Q2 2026 Earnings Call Transcript

seekingalpha.com · 14 Aug 2026

Braskem S.A. (BAK) Q2 2026 Earnings Call Transcript

Braskem S.A. (BAK) Q2 2026 Earnings Call Transcript

Braskem Q2 Earnings Call Highlights

marketbeat.com · 14 Aug 2026

Braskem Q2 Earnings Call Highlights

Braskem NYSE: BAK reported recurring EBITDA of $1.043 billion for the second quarter of 2026, supported by wider international petrochemical spreads following supply disruptions linked to the Middle East conflict. The company said the improvement was tactical rather than evidence of a structural recovery in the global petrochemical cycle, which it expects to remain pressured by overcapacity and moderate demand.

Braskem eyes out-of-court restructuring as early as this month, sources say

reuters.com · 12 Aug 2026

Braskem eyes out-of-court restructuring as early as this month, sources say

Braskem , Latin America's largest petrochemical firm, is in advanced talks for a potential out-of-court restructuring that could ​be filed as early as this month, two people familiar ‌with the matter said on Wednesday

Lallemand Biofuels & Distilled Spirits and Braskem Announce Bio-Acetone as a Coproduction Opportunity in Ethanol Facilities

businesswire.com · 28 Jul 2026

Lallemand Biofuels & Distilled Spirits and Braskem Announce Bio-Acetone as a Coproduction Opportunity in Ethanol Facilities

MONTREAL & PHILADELPHIA--(BUSINESS WIRE)--Lallemand Biofuels & Distilled Spirits (LBDS), a global leader in yeast, enzymes, microbials and nutrition, and Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK), the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale, today announced an innovative bio-acetone production platform for the corn-ethanol industry that enables producers to generate a new coproduct alongside.

Down 29.6% in 4 Weeks, Here's Why Braskem (BAK) Looks Ripe for a Turnaround

zacks.com · 6 Jul 2026

Down 29.6% in 4 Weeks, Here's Why Braskem (BAK) Looks Ripe for a Turnaround

Braskem (BAK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Braskem's Commitment to Safety Recognized with Six Texas Chemistry Council (TCC) Awards

businesswire.com · 25 Jun 2026

Braskem's Commitment to Safety Recognized with Six Texas Chemistry Council (TCC) Awards

PHILADELPHIA--(BUSINESS WIRE)-- #Awards--Braskem (BM&FBOVESPA: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK), the largest polyolefins producer in the Americas and a market leader in biopolymers, is excited to announce that its Seadrift, Oyster Creek, and La Porte facilities have received six awards from the Texas Chemistry Council (TCC) for outstanding performance and commitment to safety, community, and sustainability in 2025. Each year, the Texas Chemistry Council (TCC) and Texas Chemistry All.

Braskem (BAK) Loses 38.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

zacks.com · 19 Jun 2026

Braskem (BAK) Loses 38.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Braskem (BAK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.